J. Safra Sarasin Holding AG Purchases 19,591 Shares of UnitedHealth Group Incorporated $UNH

J. Safra Sarasin Holding AG raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 127.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,947 shares of the healthcare conglomerate’s stock after purchasing an additional 19,591 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in UnitedHealth Group were worth $11,536,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the company. Beacon Financial Strategies CORP purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. Foster Dykema Cabot & Partners LLC increased its holdings in shares of UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 34 shares in the last quarter. 1248 Management LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at $29,000. Holos Integrated Wealth LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $29,000. Finally, Hurley Capital LLC raised its position in UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.1%

Shares of UNH stock opened at $261.83 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The firm has a fifty day moving average price of $289.00 and a 200-day moving average price of $321.61. The company has a market cap of $237.66 billion, a price-to-earnings ratio of 19.85, a PEG ratio of 1.19 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same quarter in the previous year, the company posted $6.81 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 3.4%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on UNH shares. Leerink Partners reduced their price target on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. Mizuho cut their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. Barclays lowered their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a report on Friday, January 30th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.